The beta-agonist controversy revisited.
Hall
Ian P
IP
Division of Therapeutics and Molecular Medicine, Queen's Medical Centre, University Hospital, NG7 2UH, Nottingham, UK. ian.hall@nottingham.ac.uk
D000318:Adrenergic beta-Agonists / Q000494:pharmacology / Q000627:therapeutic use*; D000403:Airway Resistance / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001980:Bronchi / Q000187:drug effects / Q000502:physiology; D000242:Cyclic AMP / Q000378:metabolism / Q000502:physiology; D006801:Humans; D051379:Mice; D009126:Muscle Relaxation / Q000187:drug effects / Q000502:physiology; D009130:Muscle, Smooth / Q000187:drug effects / Q000378:metabolism; D011943:Receptors, Adrenergic, beta / Q000187:drug effects / Q000235:genetics / Q000502:physiology
D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP